Isolated splenic tuberculosis in a patient with rheumatoid arthritis

TL;DR

A 70-year-old man with rheumatoid arthritis was diagnosed with rare isolated splenic tuberculosis and successfully treated without surgery.

Contribution

This case highlights the successful management of isolated splenic TB through early diagnosis and drug treatment in an elderly RA patient.

Findings

Fine-needle aspiration confirmed Mycobacterium tuberculosis infection in the spleen.

Six months of anti-TB treatment reduced splenic lesions and prevented relapse after nine months.

Early diagnosis and treatment avoided the need for splenectomy in this patient.

Abstract

Isolated splenic tuberculosis (TB) is rare. Here, we report a case of isolated splenic TB in a 70-year-old man with rheumatoid arthritis (RA). The patient presented to the emergency department with a 3-day history of epigastric pain and hematemesis. For RA treatment, a combination of methotrexate (8 mg) and baricitinib (4 mg) had been initiated 2 years prior. Abdominal computed tomography (CT) scan revealed upper gastrointestinal hemorrhage and intrasplenic involvement. Following endoscopic hemostasis, we performed endoscopic ultrasound-guided fine-needle aspiration via the stomach due to suspected pancreatic cancer. At an outpatient follow-up visit 1 month later, fever and elevated C-reactive protein (9.02 mg/dL) levels were observed. CT imaging showed enlarged necrotic lymph nodes near the gastroesophageal junction, left mesentery of the colon, and the greater curvature of the pylorus, along with an increased low-density area in the spleen. Subsequently, upper gastrointestinal endoscopy and ultrasound-guided percutaneous fine-needle aspiration cytology were performed. Cultures from the abscesses tested positive for Mycobacterium tuberculosis, which was susceptible to isoniazid, rifampicin, ethambutol, and pyrazinamide. No lesions were identified, thus confirming a diagnosis of isolated splenic TB. Oral anti-TB treatment with four drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) was initiated. After 6 months of treatment, the splenic lesions had shrunk. Nine months after completing therapy, RA treatment was resumed without relapse. Therefore, early diagnosis and anti-TB treatment can successfully manage splenic TB without requiring splenectomy.

•Isolated splenic tuberculosis (TB) is rare, especially in the elderly with rheumatoid arthritis (RA).•Fine-needle aspiration confirmed Mycobacterium tuberculosis infection.•Six months of treatment shrank splenic lesions, no relapse after nine months.•Early diagnosis and anti-TB treatment can successfully manage splenic TB without requiring splenectomy.

Isolated splenic tuberculosis (TB) is rare, especially in the elderly with rheumatoid arthritis (RA).

Fine-needle aspiration confirmed Mycobacterium tuberculosis infection.

Six months of treatment shrank splenic lesions, no relapse after nine months.

Early diagnosis and anti-TB treatment can successfully manage splenic TB without requiring splenectomy.

Figures